• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病吞咽困难和胃轻瘫在真实世界临床实践中的管理——平衡药物和非药物方法

Management of dysphagia and gastroparesis in Parkinson's disease in real-world clinical practice - Balancing pharmacological and non-pharmacological approaches.

作者信息

Bhidayasiri Roongroj, Phuenpathom Warongporn, Tan Ai Huey, Leta Valentina, Phumphid Saisamorn, Chaudhuri K Ray, Pal Pramod Kumar

机构信息

Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

Academy of Science, Royal Society of Thailand, Bangkok, Thailand.

出版信息

Front Aging Neurosci. 2022 Aug 11;14:979826. doi: 10.3389/fnagi.2022.979826. eCollection 2022.

DOI:10.3389/fnagi.2022.979826
PMID:36034128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9403060/
Abstract

Gastrointestinal (GI) issues are commonly experienced by patients with Parkinson's disease (PD). Those that affect the lower GI tract, such as constipation, are the most frequently reported GI problems among patients with PD. Upper GI issues, such as swallowing dysfunction (dysphagia) and delayed gastric emptying (gastroparesis), are also common in PD but are less well recognized by both patients and clinicians and, therefore, often overlooked. These GI issues may also be perceived by the healthcare team as less of a priority than management of PD motor symptoms. However, if left untreated, both dysphagia and gastroparesis can have a significant impact on the quality of life of patients with PD and on the effectiveness on oral PD medications, with negative consequences for motor control. Holistic management of PD should therefore include timely and effective management of upper GI issues by utilizing both non-pharmacological and pharmacological approaches. This dual approach is key as many pharmacological strategies have limited efficacy in this setting, so non-pharmacological approaches are often the best option. Although a multidisciplinary approach to the management of GI issues in PD is ideal, resource constraints may mean this is not always feasible. In 'real-world' practice, neurologists and PD care teams often need to make initial assessments and treatment or referral recommendations for their patients with PD who are experiencing these problems. To provide guidance in these cases, this article reviews the published evidence for diagnostic and therapeutic management of dysphagia and gastroparesis, including recommendations for timely and appropriate referral to GI specialists when needed and guidance on the development of an effective management plan.

摘要

帕金森病(PD)患者常出现胃肠道(GI)问题。那些影响下消化道的问题,如便秘,是PD患者中最常报告的GI问题。上消化道问题,如吞咽功能障碍(吞咽困难)和胃排空延迟(胃轻瘫),在PD中也很常见,但患者和临床医生对此认识不足,因此常常被忽视。与PD运动症状的管理相比,医疗团队可能也认为这些GI问题不那么重要。然而,如果不进行治疗,吞咽困难和胃轻瘫都会对PD患者的生活质量以及口服PD药物的疗效产生重大影响,进而对运动控制产生负面影响。因此,PD的整体管理应包括通过采用非药物和药物方法及时有效地管理上消化道问题。这种双重方法很关键,因为许多药物策略在这种情况下疗效有限,所以非药物方法往往是最佳选择。虽然采用多学科方法管理PD患者的GI问题是理想的,但资源限制可能意味着这并不总是可行的。在“现实世界”的实践中,神经科医生和PD护理团队经常需要对出现这些问题的PD患者进行初步评估,并做出治疗或转诊建议。为了在这些情况下提供指导,本文回顾了关于吞咽困难和胃轻瘫诊断与治疗管理的已发表证据,包括在需要时及时、适当地转诊至胃肠专科医生的建议以及制定有效管理计划的指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2f/9403060/996b148ade37/fnagi-14-979826-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2f/9403060/86a061d532ed/fnagi-14-979826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2f/9403060/8d84354b737d/fnagi-14-979826-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2f/9403060/4521749976cb/fnagi-14-979826-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2f/9403060/013ec8ee10a5/fnagi-14-979826-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2f/9403060/a15672d90024/fnagi-14-979826-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2f/9403060/996b148ade37/fnagi-14-979826-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2f/9403060/86a061d532ed/fnagi-14-979826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2f/9403060/8d84354b737d/fnagi-14-979826-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2f/9403060/4521749976cb/fnagi-14-979826-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2f/9403060/013ec8ee10a5/fnagi-14-979826-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2f/9403060/a15672d90024/fnagi-14-979826-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2f/9403060/996b148ade37/fnagi-14-979826-g006.jpg

相似文献

1
Management of dysphagia and gastroparesis in Parkinson's disease in real-world clinical practice - Balancing pharmacological and non-pharmacological approaches.帕金森病吞咽困难和胃轻瘫在真实世界临床实践中的管理——平衡药物和非药物方法
Front Aging Neurosci. 2022 Aug 11;14:979826. doi: 10.3389/fnagi.2022.979826. eCollection 2022.
2
Gastroparesis and Parkinson's disease: a systematic review.胃轻瘫与帕金森病:系统综述。
Parkinsonism Relat Disord. 2012 Jun;18(5):433-40. doi: 10.1016/j.parkreldis.2011.12.004. Epub 2011 Dec 29.
3
Gut dysfunction in Parkinson's disease.帕金森病中的肠道功能障碍。
World J Gastroenterol. 2016 Jul 7;22(25):5742-52. doi: 10.3748/wjg.v22.i25.5742.
4
The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease.帕金森病患者胃轻瘫、便秘及小肠细菌过度生长综合征的治疗
Expert Opin Pharmacother. 2015;16(16):2449-64. doi: 10.1517/14656566.2015.1086747. Epub 2015 Sep 16.
5
Gastrointestinal Dysfunction in Parkinson's Disease: Current and Potential Therapeutics.帕金森病中的胃肠功能障碍:当前及潜在治疗方法
J Pers Med. 2022 Jan 21;12(2):144. doi: 10.3390/jpm12020144.
6
Parkinson's Disease and Diabetes Mellitus: Synergistic Effects on Pathophysiology and GI Motility.帕金森病与糖尿病:对病理生理学和胃肠动力的协同作用
Curr Gastroenterol Rep. 2023 May;25(5):106-113. doi: 10.1007/s11894-023-00868-7. Epub 2023 Apr 17.
7
Gastrointestinal Dysfunction in Parkinson's Disease: Neuro-Gastroenterology Perspectives on a Multifaceted Problem.帕金森病中的胃肠功能障碍:多方面问题的神经胃肠病学视角
J Mov Disord. 2023 May;16(2):138-151. doi: 10.14802/jmd.22220. Epub 2023 May 24.
8
Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson's disease.鱼藤酮诱导帕金森病大鼠模型的胃肠道病理学和微生物群改变。
Neurotoxicology. 2018 Mar;65:174-185. doi: 10.1016/j.neuro.2018.02.013. Epub 2018 Feb 20.
9
Gastrointestinal dysfunction in Parkinson's disease.帕金森病的胃肠功能障碍。
J Neurol. 2020 May;267(5):1377-1388. doi: 10.1007/s00415-020-09723-5. Epub 2020 Jan 27.
10
A practical review of gastrointestinal manifestations in Parkinson's disease.帕金森病胃肠道表现的实用综述
Parkinsonism Relat Disord. 2017 Jun;39:17-26. doi: 10.1016/j.parkreldis.2017.02.029. Epub 2017 Feb 23.

引用本文的文献

1
Management of Gastrointestinal Symptoms in Parkinson's Disease.帕金森病胃肠道症状的管理
J Cent Nerv Syst Dis. 2025 Aug 13;17:11795735251370014. doi: 10.1177/11795735251370014. eCollection 2025.
2
Parkinsonism-hyperpyrexia syndrome due to gastroparesis treated with subcutaneous foslevodopa: a case report.胃轻瘫所致帕金森综合征-高热综合征经皮下注射左旋多巴治疗:1例报告
J Neurol. 2025 Aug 8;272(9):564. doi: 10.1007/s00415-025-13313-8.
3
Vital nutrition: enhancing health in advanced Parkinson's disease with device-aided therapies.

本文引用的文献

1
Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction.肉毒杆菌毒素注射治疗上食管括约肌功能障碍。
Toxins (Basel). 2022 Apr 30;14(5):321. doi: 10.3390/toxins14050321.
2
A Narrative Review of Specialist Parkinson's Nurses: Evolution, Evidence and Expectation.帕金森病专科护士的叙事综述:演变、证据与期望
Geriatrics (Basel). 2022 Apr 7;7(2):46. doi: 10.3390/geriatrics7020046.
3
Improving functional disability in patients with tremor: A clinical perspective of the efficacies, considerations, and challenges of assistive technology.
重要营养:通过设备辅助疗法改善晚期帕金森病患者的健康状况
J Neural Transm (Vienna). 2025 Apr 24. doi: 10.1007/s00702-025-02935-x.
4
Zoster Sine Herpete Affecting Multiple Lower Cranial Nerves Presenting Severe Dysphagia in a Patient with Parkinson's Disease.帕金森病患者出现无疱疹性带状疱疹累及多条低位颅神经并导致严重吞咽困难
Intern Med. 2025 Apr 15;64(8):1245-1248. doi: 10.2169/internalmedicine.4250-24. Epub 2024 Sep 4.
5
User-centred design, validation and clinical testing of an anti-choking mug for people with Parkinson's disease.以用户为中心的设计、验证和临床测试一种用于帕金森病患者的防呛水杯。
Sci Rep. 2024 Jun 19;14(1):14165. doi: 10.1038/s41598-024-65071-8.
6
Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson's Disease from Mice to Human.超越微生物群:从小鼠到人类理解肠神经系统在帕金森病中的作用
Biomedicines. 2023 May 27;11(6):1560. doi: 10.3390/biomedicines11061560.
7
A systematic review and meta-analysis of acupuncture in Parkinson's disease with dysphagia.针刺治疗帕金森病吞咽困难的系统评价与Meta分析
Front Neurol. 2023 May 26;14:1099012. doi: 10.3389/fneur.2023.1099012. eCollection 2023.
8
Gastrointestinal Dysfunction in Parkinson's Disease: Neuro-Gastroenterology Perspectives on a Multifaceted Problem.帕金森病中的胃肠功能障碍:多方面问题的神经胃肠病学视角
J Mov Disord. 2023 May;16(2):138-151. doi: 10.14802/jmd.22220. Epub 2023 May 24.
9
Activation Patterns of Functional Brain Network in Response to Action Observation-Induced and Non-Induced Motor Imagery of Swallowing: A Pilot Study.吞咽动作观察诱发及非诱发运动想象下功能性脑网络的激活模式:一项初步研究
Brain Sci. 2022 Oct 21;12(10):1420. doi: 10.3390/brainsci12101420.
改善震颤患者的功能障碍:辅助技术的疗效、考虑因素和挑战的临床视角。
J Neurol Sci. 2022 Apr 15;435:120197. doi: 10.1016/j.jns.2022.120197. Epub 2022 Feb 19.
4
Parkinson's Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats.帕金森病药物改变健康大鼠的小肠运动和微生物组成。
mSystems. 2022 Feb 22;7(1):e0119121. doi: 10.1128/msystems.01191-21. Epub 2022 Jan 25.
5
Effectiveness of Interventions for Dysphagia in Parkinson Disease: A Systematic Review.帕金森病吞咽障碍干预措施的有效性:系统评价。
Am J Speech Lang Pathol. 2022 Jan 18;31(1):463-485. doi: 10.1044/2021_AJSLP-21-00145. Epub 2021 Dec 10.
6
Gut microbiome in Parkinson's disease: New insights from meta-analysis.帕金森病的肠道微生物组:荟萃分析的新见解。
Parkinsonism Relat Disord. 2022 Jan;94:1-9. doi: 10.1016/j.parkreldis.2021.11.017. Epub 2021 Nov 17.
7
Six-Year Follow-Up of Dysphagia in Patients with Parkinson's Disease.帕金森病患者吞咽困难的 6 年随访。
Dysphagia. 2022 Oct;37(5):1271-1278. doi: 10.1007/s00455-021-10387-0. Epub 2021 Nov 26.
8
How to Optimize the Effectiveness and Safety of Parkinson's Disease Therapy? - A Systematic Review of Drugs Interactions with Food and Dietary Supplements.如何优化帕金森病治疗的效果和安全性?——药物与食物和膳食补充剂相互作用的系统评价。
Curr Neuropharmacol. 2022;20(7):1427-1447. doi: 10.2174/1570159X19666211116142806.
9
Severity of dysphagia is associated with hospitalizations and mortality in patients with Parkinson's disease.吞咽困难的严重程度与帕金森病患者的住院率和死亡率相关。
Neurogastroenterol Motil. 2022 Jun;34(6):e14280. doi: 10.1111/nmo.14280. Epub 2021 Oct 10.
10
Consensus on the treatment of dysphagia in Parkinson's disease.帕金森病吞咽障碍治疗的专家共识。
J Neurol Sci. 2021 Nov 15;430:120008. doi: 10.1016/j.jns.2021.120008. Epub 2021 Sep 27.